This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/522873-biontech-pfizer-covid-vaccine-storage/

The article has changed 3 times. There is an RSS feed of changes available.

Version 0 Version 1
BioNTech/Pfizer to request approval for new Covid-19 shot that lasts up to 6 months at fridge temperatures BioNTech/Pfizer to request approval for new Covid-19 shot that lasts up to 6 months at fridge temperatures
(4 months later)
The CEO of BioNTech has said the company and its US partner Pfizer will seek approval for a new version of their Covid-19 vaccine that can be stored at normal refrigerator temperatures for up to six months.The CEO of BioNTech has said the company and its US partner Pfizer will seek approval for a new version of their Covid-19 vaccine that can be stored at normal refrigerator temperatures for up to six months.
At a webcast event organized by the Financial Times on Tuesday, BioNTech’s CEO and co-founder Ugur Sahin said the new version of their much sought-after Covid-19 vaccine could be stored in temperature between two and eight degrees Celsius for a period of up to six months. At a webcast event organized by the Financial Times on Tuesday, BioNTech’s CEO and co-founder Ugur Sahin said the new version of their much sought-after Covid-19 vaccine could be stored in temperature between two and eight degrees Celsius for a period of up to six months. 
“Our first formulation had to be stored and shipped at -80 degrees. We now have a formulation, which is not yet approved ... that can be stored at two to eight degrees,” Sahin told those watching. “Our first formulation had to be stored and shipped at -80 degrees. We now have a formulation, which is not yet approved ... that can be stored at two to eight degrees,” Sahin told those watching. 
“We will most likely reach six months’ stability at two to eight degrees,” he stated, adding that data packages were being readied to be sent out to regulators.“We will most likely reach six months’ stability at two to eight degrees,” he stated, adding that data packages were being readied to be sent out to regulators.
While the current BioNTech/Pfizer jab has been widely used and is in high demand, the requirement to store the shot at super-cold temperatures means it has little utility in countries or regions without a network of such storage capabilities.While the current BioNTech/Pfizer jab has been widely used and is in high demand, the requirement to store the shot at super-cold temperatures means it has little utility in countries or regions without a network of such storage capabilities.
At the same video conference, Sahin said BioNTech and Pfizer have been able to further increase production capacity of their Covid-19 vaccine, upping supply to around three billion doses in 2021.At the same video conference, Sahin said BioNTech and Pfizer have been able to further increase production capacity of their Covid-19 vaccine, upping supply to around three billion doses in 2021.
If you like this story, share it with a friend!If you like this story, share it with a friend!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.